D-Wave Quantum Faces a Defining Week: A Scientific Clash, a Federal Windfall, and an Investor Showdown

D-Wave shares rose 6% after securing $100M in CHIPS Act funding, while rebutting a quantum supremacy challenge. Revenue fell 81%, but bookings hit a record $33.4M.

The quantum computing race entered a new gear this week as D?Wave Quantum found itself juggling a scientific rebuttal, a federal cash infusion, and a packed investor calendar. The stock closed at $29.15 on Thursday, up 6.07%, after earlier trading at €25.30 in Europe — a session that saw some 54 million shares change hands, volumes 69% above the daily norm. The rally pushed the market capitalisation to just under $11 billion, though the stock remains 33% off its 52?week high of $38.48 (€38.48).

The immediate catalyst was a $100 million funding pledge from the U.S. Commerce Department under the CHIPS and Science Act. D?Wave signed a non?binding letter of intent on May 21, with the money earmarked for developing superconducting annealing and gate?model systems. In return, the federal government will take minority stakes — a strategic shift in Washington’s approach to backing frontier technology. The move injected fresh confidence into a sector that has been wrestling with questions about real?world viability.

However, the stock’s trajectory has not been smooth. On May 26, D?Wave issued a formal rebuttal to a study from the Flatiron Institute that challenged the company’s claims of quantum supremacy. The researchers argued that classical simulations could reproduce results D?Wave had presented as proof. In an 8?K filing, the company pushed back, insisting that the classical tensor?network methods failed on the hardest problem instances and specific 3D spin?glass topologies. Its own calculations suggested the Frontier supercomputer would need roughly one million years to match the simulation quality D?Wave achieved. The exchange underscores a vulnerability: quantum supremacy remains the industry’s central sales pitch, and any scientific challenge risks unsettling valuations.

Amid the noise, D?Wave’s business numbers paint a mixed picture. First?quarter revenue fell 81% to $2.9 million, reflecting the absence of a large system sale that had boosted the prior?year period. Yet bookings surged 1,994% to a record $33.4 million, anchored by a $20 million system sale to Florida Atlantic University and a $10 million QCaaS contract with a Fortune 100 company. The balance sheet shows $588.4 million in cash and equivalents.

Wall Street has largely held its ground. Of 17 analysts covering the stock, 14 rate it a buy, two a hold, and one a sell. The consensus 12?month price target sits around $34. Mizuho trimmed its target to $29 but kept its outperform rating, citing near?term volatility. Rosenblatt Securities stands at $43, the highest on the Street. The market is also digesting insider activity: CFO John M. Markovich sold 328,752 shares on May 22 at prices between $27.00 and $28.61 after exercising options. Simultaneously, D?Wave updated its share count to 367.25 million outstanding shares, including 3.17 million exchangeable units.

All of this sets the stage for a landmark event. On June 1, D?Wave will host its first?ever investor day at the New York Stock Exchange under the tagline “The D?Wave Difference.” The management is expected to detail the Advantage2 system, which boasts more than 4,400 qubits, and lay out the dual?platform strategy combining annealing and gate?model architectures. The timing is deliberate: with a scientific controversy unresolved and a federal grant in hand, the company needs to convince investors that its technology can deliver commercially where classical computers cannot. The outcome of that day could define D?Wave’s narrative for the rest of the year.